Revascularization

Complete Revascularization Benefits Older MI Patients Regardless of Renal Function: Insights from the FIRE Trial

By MedXY 01/17/2026

A sub-analysis of the FIRE trial demonstrates that physiology-guided complete revascularization significantly reduces major adverse cardiovascular events in patients aged 75 and older, irrespective of baseline kidney function, without increasing the risk of contrast-associated acute kidney injury.

Cardiology Clinical Updates Radiology Specialties

FFR-Guided Complete Revascularization Enhances Outcomes in NSTEMI with Multivessel Disease: Insights from the SLIM Trial

By MedXY 09/01/2025

The SLIM trial demonstrates that fractional flow reserve–guided complete revascularization during the index procedure significantly reduces major adverse events at one year in patients with NSTEMI and multivessel disease, primarily by lowering repeat revascularizations.

Cardiology General Surgery news Specialties

Impact of Red Blood Cell Transfusion Strategies on Outcomes in Acute Myocardial Infarction Patients Undergoing Revascularization: Insights from the MINT Trial

By MedXY 08/17/2025

This prespecified analysis of the MINT trial evaluates how liberal versus restrictive red blood cell transfusion strategies affect 30-day outcomes in acute MI patients, focusing on those undergoing revascularization, revealing nuanced risk profiles for cardiac death based on revascularization status.